LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
  • AstraZeneca PLC (LSE: AZN) Latest News

    Female Doctor In White Coat Having Meeting With Woman Patient In Office
    Investing Articles

    6 super investors hold this FTSE 100 stock. Should I buy it too?

    Some world-renowned investors have selected this FTSE 100 stock for their mega-portfolios. But have their investments been lucrative and is…

    Read more »

    Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
    Investing Articles

    Down 10%, the most valuable stock on the FTSE 100 is starting to look cheap!

    Dr James Fox investigates whether the FTSE 100's most valuable stock, AstraZeneca, looks like a good buy after its 10%…

    Read more »

    Mindful young woman breathing out with closed eyes, calming down in stressful situation, working on computer in modern kitchen.
    Investing Articles

    2 FTSE 100 shares to buy in the UK stock market crash

    Following the mini budget, FTSE 100 shares took a beating as the index sank below 7,000. Our writer picks two…

    Read more »

    A young black man makes the symbol of a peace sign with two fingers
    Investing Articles

    2 no-brainer value stocks I think I’ll buy for Q4

    Jon Smith reveals two value stocks that he's thinking of buying to boost his portfolio performance as we go into…

    Read more »

    Female Doctor In White Coat Having Meeting With Woman Patient In Office
    Investing Articles

    If I’d invested £1,000 in AstraZeneca shares at the start of 2022, here’s what I’d have now

    AstraZeneca has been a top-performing FTSE 100 share in recent years. Roland Head wonders if this FTSE 100 pharma firm…

    Read more »

    Yellow number one sitting on blue background
    Investing Articles

    1 FTSE 100 stock that should continue to outperform long term

    The pharmaceutical company AstraZeneca is a FTSE 100 stock that stands out amongst Footsie companies for both its consistent growth…

    Read more »

    Question with the text “Top UK Blue-Chip Stocks” and The Motley Fool jester cap logo
    Page

    Top UK Blue-Chip Stocks of 2024

    Blue-chip stocks are great portfolio builders. Here, we look at the top companies in the UK by market cap and…

    Read more »

    Arrow symbol glowing amid black arrow symbols on black background.
    Investing Articles

    Is this FTSE 100 pharma giant a growth stock in disguise?

    Growth stocks are companies that are expected to increase sales and earnings faster than the market average. But they're often…

    Read more »

    HEALTH in toy blocks with the text “Investing in Healthcare Top UK Healthcare Stocks” and The Motley Fool jester cap logo
    Page

    Investing in Healthcare: Top UK Healthcare Stocks of 2024

    Explore the top UK healthcare stocks delivering life-saving treatments and discover an explosive multi-trillion-dollar investment opportunity.

    Read more »

    Engineer Project Manager Talks With Scientist working on Computer
    Investing Articles

    AstraZeneca shares fall after boosting guidance! Is this a buying opportunity?

    AstraZeneca shares were down around 2% in early morning trading despite registering positive results. So, what's going on here?

    Read more »

    Young female analyst working at her desk in the office
    Investing Articles

    3 top UK shares to consider

    Ahead of a possible recession, many top UK shares have fallen this year. Our writer considers the best stock market…

    Read more »

    Mixed-race female couple enjoying themselves on a walk
    Investing Articles

    A soaring FTSE 100 stock to buy at its all-time high

    Many FTSE 100 stocks have suffered due to macroeconomic pressures. However, this pharma stock has just reached its all-time high.

    Read more »